Skip to main content
Caplight Logo









Nunatak Biotech

Nunatak Biotech

Private
Buenos AiresHealthcare & Life Scienceshttps://nunatakbio.com/

Last Round

Accelerator

Jun 19, 2025

Total Funding Raised

$107,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nunatak Biotech is an AgTech company that develops microbial bioinputs derived from extremophile microorganisms to improve crop resilience, soil health, and agricultural productivity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

agricultural biotechnologyagtechmicrobial bioinputssoil healthagricultural biologicalscrop resiliencemicrobial consortiaextremophilessynthetic ecologyplant-microbiome symbiosisabiotic stress tolerancebiologicalssustainable agriculturemicrobial screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nunatak Biotech Comparables

Compare Nunatak Biotech with similar companies based on industry and business-model similarity.

Nunatak Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Symbiomics
84%
Puna Bio
83%
endophyte Inc.
80%

Nunatak Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 19, 2025

Key People

Founding team and executive leadership

Julia Mensa

Co-founder CEO

Founding Team

María Martha Martorell

COO

Executive Team

Nunatak Biotech Investors

Notable investors and investment history

Nunatak Biotech investors
InvestorRounds
SVG Ventures|THRIVEAccelerator
Eatable AdventuresAccelerator
German AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 35% MoM.

  • Apr 17, 2026

    Monthly visitors grew 192% MoM from 150 to 438.

Nunatak Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nunatak Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nunatak Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBuenos Aires
Employee Range7
Year Founded2023
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?